Abdulkareem Alaiya

Crosstalk Between Aryl Hydrocarbon Receptor (AhR) and BCL-2 Pathways Suggests the Use of AhR Antagonist to Maintain Normal Differentiation State of Mammary Epithelial Cells During BCL-2 Inhibition Therapy.

H. Korashy, Mohamed W. Attwa, S. Bakheet, 2022, Journal of advanced research.